Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Intravenous WCK 771
NCT05640531
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Bioavailability
Interventions
DRUG:
WCK 771 IV Infusion
OTHER:
Placebo IV Infusion
Sponsor
Wockhardt